| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/24/2013 | US8541008 Monoclonal antibody against an ALS1 protein that specifically binds an epitope in an N-terminal domain and which inhibits adherence of Candida albicans to endothelial cells. |
| 09/24/2013 | US8541007 Vaccines against chlamydial infection |
| 09/24/2013 | US8541006 Methods and devices for the detection of biofilm |
| 09/24/2013 | US8541005 Cysteine-tagged streptococcal protein G variant |
| 09/24/2013 | US8541003 Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| 09/24/2013 | US8541002 Vaccine for treatment and prevention of herpes simplex virus infection |
| 09/24/2013 | US8541000 Variant of mite allergen and uses thereof |
| 09/24/2013 | US8540999 Allergenic proteins and peptides from Japanese cedar pollen |
| 09/24/2013 | US8540998 Methods for treating cancer using ephrin type-A receptor 10 antibodies conjugated to cytotoxic agents |
| 09/24/2013 | US8540997 Complement receptor 1 and 2 fusion proteins |
| 09/24/2013 | US8540996 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof |
| 09/24/2013 | US8540995 Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza A viruses and uses thereof |
| 09/24/2013 | US8540994 H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance |
| 09/24/2013 | US8540993 Methods of treatment using IL-18 receptor antigen binding proteins |
| 09/24/2013 | US8540992 Methods and vectors for generating asialylated immunoglobulins |
| 09/24/2013 | US8540991 Monoclonal antibodies against PCBP-1 antigens, and uses therefor |
| 09/24/2013 | US8540990 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same |
| 09/24/2013 | US8540989 Compositions and methods for treating and diagnosing cancer |
| 09/24/2013 | US8540988 Antibodies that bind polypeptides involved in the process of bone remodeling |
| 09/24/2013 | US8540987 Composition for neutralizing botulinus toxin type-A, and human anti-botulinus toxin type-A antibody |
| 09/24/2013 | US8540986 Toll-like receptor 3 antagonists |
| 09/24/2013 | US8540982 Methods for inducing a natural killer (NK) cell-mediated immune response and for increasing NK cell activity |
| 09/24/2013 | US8540964 Polyvalent conjugate vaccine for cancer |
| 09/24/2013 | CA2770851C Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 09/24/2013 | CA2693956C Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant |
| 09/24/2013 | CA2689856C Composition and method for stable injectable liquids |
| 09/24/2013 | CA2562550C Phosphorylcholine conjugates and corresponding antibodies |
| 09/24/2013 | CA2552788C Fc region variants |
| 09/24/2013 | CA2542691C Il-6 antagonist for use as mesothelioma therapeutic agent |
| 09/24/2013 | CA2517010C Plasmid dna in combination with recombinant vsv for use in prime-boost immunization regimens |
| 09/24/2013 | CA2515453C Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury |
| 09/24/2013 | CA2507099C Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis |
| 09/24/2013 | CA2448427C Molecules and methods for inhibiting shedding of kim-1 |
| 09/24/2013 | CA2446704C Method for preparing human immunoglobulin concentrates for therapeutic use |
| 09/24/2013 | CA2443294C Remedies for infant chronic arthritis-relating diseases |
| 09/24/2013 | CA2425669C Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/24/2013 | CA2405557C Albumin fusion proteins |
| 09/24/2013 | CA2318857C Use of heregulin as an epithelial cell growth factor |
| 09/20/2013 | CA2809513A1 Process for obtaining an igg composition through heat treatment |
| 09/19/2013 | WO2013138776A1 Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
| 09/19/2013 | WO2013138735A1 Cancer therapeutics |
| 09/19/2013 | WO2013138716A1 The filamentous bacteriophage as an angiogenesis modulator |
| 09/19/2013 | WO2013138670A1 Yellow fever virus ns5 mutants as flavivirus vaccine candidates |
| 09/19/2013 | WO2013138662A1 Antisense conjugates for decreasing expression of dmpk |
| 09/19/2013 | WO2013138586A1 Human anti-cd27 antibodies, methods and uses |
| 09/19/2013 | WO2013138371A1 Methods for treating pancreatic cancer using combination therapies comprising an anti-erbb3 antibody |
| 09/19/2013 | WO2013138368A1 Substances and methods for the treatment of cerebral amyloid angiopathy related conditions or diseases |
| 09/19/2013 | WO2013138337A1 Suppressor cell function inhibition following listeria vaccine treatment |
| 09/19/2013 | WO2013138334A1 Adjuvant and vaccine compositions |
| 09/19/2013 | WO2013138244A2 Treatment of multiple sclerosis with anti-cd19 antibody |
| 09/19/2013 | WO2013138241A1 Human autotaxin antibodies and methods of use |
| 09/19/2013 | WO2013137969A1 Treatment of migraine headaches with presynaptic neurotoxin |
| 09/19/2013 | WO2013137854A1 Antibodies that bind to nanoparticles |
| 09/19/2013 | WO2013137782A1 Agent for the treatment of hepatitis c virus |
| 09/19/2013 | WO2013137686A1 Gremlin-1 antibody |
| 09/19/2013 | WO2013136086A1 A negative modulator of hedgehog signalling for use in treating th2 -mediated diseases |
| 09/19/2013 | WO2013135655A1 Bi-specific adapters |
| 09/19/2013 | WO2013135588A1 Novel binding molecules with antitumoral activity |
| 09/19/2013 | WO2013135274A1 Aluminium compounds for use in therapeutics and vaccines |
| 09/19/2013 | WO2013112856A3 Multifunctional nanomaterials for the treatment of cancer |
| 09/19/2013 | WO2013087857A3 Antibodies against c. difficile toxins |
| 09/19/2013 | WO2013034660A9 Anti-siglec-15 antibodies and uses thereof |
| 09/19/2013 | WO2013003353A3 Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
| 09/19/2013 | WO2012155055A9 Integrin-targeted imaging of inflammation in vascular remodeling |
| 09/19/2013 | US20130245234 Vmp-like sequences of pathogenic borrelia |
| 09/19/2013 | US20130245226 Antibodies To Non-Functional P2X7 Receptor |
| 09/19/2013 | US20130245097 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 09/19/2013 | US20130244927 Polynucleotides encoding signal peptide-containing molecules |
| 09/19/2013 | US20130244925 Molecules mimicking an autoantibody idiotype and compositions containing same |
| 09/19/2013 | US20130243850 Adjuvant |
| 09/19/2013 | US20130243820 Modification of exosomal components for use as a vaccine |
| 09/19/2013 | US20130243818 Composition Comprising Sortase Anchored Surface Proteins of Streptococcus Uberis |
| 09/19/2013 | US20130243817 Vaccine compositions |
| 09/19/2013 | US20130243816 Influenza hemagglutinin and neuraminidase variants |
| 09/19/2013 | US20130243815 Inhibitors of dsrna-dependent protein kinase (pkr) as enhancers of bunyavirus live-attenuated vaccines |
| 09/19/2013 | US20130243814 Microbial delivery system |
| 09/19/2013 | US20130243813 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 09/19/2013 | US20130243812 Replication-Defective Flavivirus Vaccines and Vaccine Vectors |
| 09/19/2013 | US20130243811 Immunostimulatory oligonucleotides and uses thereof |
| 09/19/2013 | US20130243810 Synergistic immunogenic compositions based on protein antigens combined with pertussis cell antigen and inactivated toxins |
| 09/19/2013 | US20130243808 Compositions and methods for vaccinating humans and animals against enveloped viruses |
| 09/19/2013 | US20130243807 Neisseria meningitidis compositions and methods thereof |
| 09/19/2013 | US20130243804 Peptide Sequences and Compositions |
| 09/19/2013 | US20130243803 Therapies, vaccines, and predictive methods for infectious salmon anemia virus |
| 09/19/2013 | US20130243801 Epitope therapy for infectious diseases |
| 09/19/2013 | US20130243800 Hla-dr-binding antigen peptide derived from wt1 |
| 09/19/2013 | US20130243798 Peptides for vaccine against birch allergy |
| 09/19/2013 | US20130243796 Genetic products differentially expressed in tumors and use thereof |
| 09/19/2013 | US20130243794 Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses |
| 09/19/2013 | US20130243791 Pain treatment |
| 09/19/2013 | US20130243790 Methods Of Treating Obesity By Inhibiting Nicotinamide N-Methyl Transferase (NNMT) |
| 09/19/2013 | US20130243786 Treatment of juvenile rheumatoid arthritis (jra) |
| 09/19/2013 | US20130243785 Selective removal of age-modified cells for treatment of atherosclerosis |
| 09/19/2013 | US20130243784 METHODS FOR REDUCING LIPOPROTEIN(a) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9) |
| 09/19/2013 | US20130243782 Hypoxia-induced mitogenic factor |
| 09/19/2013 | US20130243781 Signal peptide-containing proteins |
| 09/19/2013 | US20130243780 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 09/19/2013 | US20130243774 Notch1 binding agents and methods of use thereof |
| 09/19/2013 | US20130243773 Recombinant production of mixtures of antibodies |
| 09/19/2013 | US20130243768 Multimeric proteins and methods of making and using same |